Oaktree Acquisition Corp. III Life Sciences (OACC)
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Sector: Blank Checks
Industry: Shell Companies
Oaktree Acquisition Corp. II
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 19.78M shares outstanding
USOaktree Acquisition Corp. III Life Sciences does not have significant operations.
The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe.
The company was incorporated in 2024 and is based in Los Angeles, California.
Leadership
George A. Martinez
Chief Financial Officer, Principal Accounting & Principal Financial Officer
Mathew Pendo
Chief Operation Officer
Zaid Pardesi
Chief Executive Officer & Director
Employees
--
Country
US
Sector
Financial Services
Website
oaktreeacquisitioncorp.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Oaktree Acquisition Holdings III LS, LLC | 10% Owner | Conversion of Derivative | 4.80M | -- | Oct 23, 2026 |
| Oaktree Acquisition Holdings III LS, LLC | 10% Owner | Conversion of Derivative | 4.80M | -- | Oct 23, 2026 |
| Oaktree Acquisition Holdings III LS, LLC | 10% Owner | Conversion of Derivative | 34.0K | $339.8K | Oct 30, 2024 |
| Oaktree Acquisition Holdings III LS, LLC | 10% Owner | Other | 231.5K | -- | Oct 30, 2024 |
| Oaktree Acquisition Holdings III LS, LLC | 10% Owner | Conversion of Derivative | 6.8K | -- | Oct 30, 2024 |
| Oaktree Acquisition Holdings III LS, LLC | 10% Owner | Conversion of Derivative | 34.0K | -- | Oct 30, 2024 |
| Name | Shares | % | Source |
|---|---|---|---|
 Oaktree Acquisition Holdings III LS, LLC 10% Owner | 5.4M | 27.2% | FORM 4 |
AQR Arbitrage LLC | 1.3M | 6.7% | 13F |
Fort Baker Capital Management LP | 1.1M | 5.6% | 13F |
Decagon Asset Management LLP | 1.1M | 5.5% | 13F |
Empyrean Capital Partners, LP | 900.0K | 4.5% | 13F |
Barclays PLC · may incl. warrants· filed Feb 2026 | 861.6K | 4.4% | 13G |
D. E. Shaw & Co., Inc. | 861.6K | 4.4% | 13F |
THE GOLDMAN SACHS GROUP, INC. · also on 13F· may incl. warrants· filed Aug 2025 | 803.5K | 4.1% | 13G |
BOUSSARD & GAVAUDAN GESTION SAS | 720.0K | 3.6% | 13F |
Boussard & Gavaudan Investment Management LLP | 720.0K | 3.6% | 13F |
Insiders
based on 19.78M shares outstanding
US30d Avg
68.97K
60d Avg
58.13K
90d Avg
58.30K